Epidemiologic study results addressing the carcinogenicity of six compounds related to vinyl chloride (vinylidene chloride, trichloroethylene, perchloroethylene, carbon tetrachloride, ethylene dibromide and epichlorohydrin) are reviewed.
Introduction
In the early 1970's, bioassays demonstrated the induction of cancer at multiple sites in experimental animals exposed to vinyl chloride (VC) by several routes of administration. Subsequently, epidemiologic studies confirmed an excess cancer risk of multiple sites among individuals employed in operations using VC (1) . As a result of these observations, attention was focused on the toxicity of structural analogs of vinyl chloride. This review will present information on the potential for human exposure and the carcinogenic risks associated with exposure to these substances.
Magnitude of Exposure
Studies of occupational groups exposed to six VC-related substances have been conducted. Esti tional Hazard Survey data and current OSHA permissible exposure limits expressed as 8-hr timeweighted averages (TWA), for levels of occupational exposure to these substances are presented in Table 1 . These substances are produced in high volume, and exposures involve large numbers of workers. As some of these substances were not produced in relatively high volume until the 1950's (2), the latency period required for the statistically sensitive evaluation of any potential cancer risk in the exposed individuals has not yet been achieved for a large proportion of exposed individuals. Experimental evidence now demonstrates that many of the compounds structurally and industri-ally related to vinyl chloride are carcinogenic (3). Many of these substances are also mutagenic (4, 5) . Bioassay study results have demonstrated the induction of tumors at multiple sites as a result of exposure to EDB and CCI4. Cancers of the respiratory tract have been induced in experimental animals exposed to EDB and ECH. Liver cancers have been induced in animals exposed to VDC and EDB as well as to the industrial solvents TCE, PCE and CC14.
While these experimental studies were being conducted, the Interagency Regulatory Liaison Group (IRLG) was drafting documentation guidelines for epidemiologic studies (6) . Also during this time, hearings on OSHA's cancer policy were proceeding, with much emphasis given to the role of nonpositive epidemiologic studies in qualitative risk assessment. The epidemiologic considerations, expressed in the IRLG guidelines and discussed in the OSHA cancer policy (7) will be used in this paper to assess the methodology and results of several epidemiologic studies of populations potentially exposed to one or more of the structural analogs of vinyl chloride.
Epidemiologic Study Results
A study of workers exposed to ECH was reported by Enterline in 1978 (8) . These data were analyzed by using the NIOSH life table program (9) and are presented in the summary data Of the substances reviewed, only the studies of workers exposed to ECH and to dry cleaning and degreasing solvents suggest an elevated risk of cancer. The excess liver cancer in the studies by Blair et al. (13, 14) is noteworthy in view of experimental study results demonstrating the induction of liver cancer with the same industrial solvents to which these workers were exposed. The remaining studies report no significant excess of cancer mortality. However, it is apparent that each of these "negative" cohort studies did not consist of a sufficient sample size and latency period to permit any meaningful conclusion regarding carcinogenic risk. The probability of identifying an excess cancer risk in the study population, if in fact it is present, is referred to as the power of the study. The power for the cohort studies reviewed was calculated based on the methods of Cutler et al. (16) and Beaumont and Breslow (1 7). Table 4 shows the Environmental Health Perspectives observed and expected number of total cancer of lung cancer deaths, the minimum number of deaths needed to observe the respective significant excesses and the resultant power to identify a 50% increase in the risk. The data are calculated for the total cohorts and the subcohorts with 10 or more or 15 or more years since initial exposure, as indicated in the studies. In order to conclude that the rate of cancer in the study population is greater than the rate of cancer in the control population, the number of observed cancer deaths must equal or exceed the minimum number of deaths required, as calculated using the Poisson distribution. The power calculations were based on the ability to detect an increase of 50% in the overall cancer risk of the study population, i.e., a relative risk of 1.5. [Criteria established by OSHA (7) for adequate sensitivity and specificity of an epidemiologic study require the ability to detect a relative risk of 1.5 in site-specific cancer risk.] The power of each study was determined by using the expected number of cancer deaths generated by the respective comparison population rate. The power to detect a 50% increase in total cancer mortality for the entire cohort ranges from 0.12, as shown for the VDC study of Ott et al., (11) to 0.52 for the Enterline study of ECH (8) 3.4 for the total cohort and 25.0 for the high exposure subcohort. As stated by OSHA (7), the group of exposed subjects must be large enough to permit detection at least a 50% increase in site-specific cancer incidence in comparison to the control population. Cohort mortality studies such as these do not meet these criteria and therefore lack the sensitivity and specificity to detect an excessive cancer risk.
Conclusion
Although experimental studies have now demonstrated the carcinogenicity and mutagenicity of VC related compounds, in general, epidemiologic studies available for review do not allow for the assessment of carcinogenic risk among humans exposed to these substances. This conclusion is based on the observation that all of the cohort studies reviewed lacked sufficient statistical power because of the small sample sizes. Furthermore, individuals were not followed over an adequate period of time to allow cancers to become clinically manifest.
Although information presented indicates that all of the substances studied are high production volume chemicals with large estimated numbers of exposed workers, the number of workers available for study who have achieved an adequate latency period is small. The retention of personnel records containing the information necessary for epidemiologic study of health hazards is not a requirement in the United States and adds to the problem of insufficient sample sizes available for study. On the basis of these observations, it is apparent that qualitative carcinogenic risk of a specific chemical substance to humans must be estimated through the conduct of experimental studies.
